Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report April 25, 2018 Irvin Jackson Add Your CommentsAmid concerns about reports of serious brain inflammation risks with Zinbryta, the effective multiple sclerosis drug was removed from the market last month, leading researchers to highlight that development of new drugs must be contingent on maintaining or improving on the risk-benefit profile of other available multiple sclerosis treatments.Zinbryta (daclizumab) was an injection drug sold by Biogen and AbbVie, which was just introduced in 2016. The FDA has approved Zinbryta for the treatment of adult patients with relapsing forms of multiple sclerosis. Due to a risk of liver injury linked to Zinbryta side effects, the drug was made available subject to a Risk Evaluation and Mitigation Strategy (REMS) program in the U.S., and regulators only recommended it as a treatment for individuals who have failed to respond to other first-line MS drugs.Following reports of problems with Zinbryta brain inflammation, including cases of encephalitis and meningoecephalitis, the drug makers announced that they were voluntarily removing the drug from the market worldwide in March 2018.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn a report published in the Spanish medical journal Revista de Neurologia on April 16, researchers point out that Zibryta was show to be effective at slowing the inflammation process of multiple sclerosis. However problems with encephalitis, autoimmune issues and other adverse health effects meant it never seriously could have been a widespread MS drug, raising questions about the drug development and approval process.Researchers conducted a “post-mortem” on the drug, noting that Zinbryta development started out as a possible leukemia therapy in the late 90s, but its immune suppressing abilities were later focused toward the treatment of MS. Even then, it showed a number of potential safety problems.Production was temporarily stopped in 2009, but not due to the safety signals, but instead due to a perceived lack of profitability in the face of other alternative treatments. Recasting it as an MS drug gave it new life, but the safety problems persisted.Francisco Carlos Perez Miralles, of Hospital Universitari i Politecnic La Fe, in Valencia, Spain, indicates in the report that Zinbryta was effective in preventing relapses, to the point that it was on part with first-line MS drugs.“On the other hand, it presents safety problems that have meant that the different drug agencies imposed an important restriction on their use,” the report determines. “In any case, although the pharmacovigilance systems have acted quickly, a debate is opened on the bidding of new drugs in MS, especially in those with an unfavorable risk-benefit profile compared to those currently in use.”Only about 8,000 individuals worldwide have used Zinbryta, highlighting the serious brain inflammation risks with at least 12 reports known to be linked to use of the drug.At least three Zinbryta deaths have been reported, all of which occurred in the United States, which led the FDA to launch an investigation into the reports. The agency was reassessing the drugโs safety profile when European regulatorsย and the manufacturers decided the drug should be pulled from the market.Due to questions about whether the medication was adequately researched, and whether proper warnings were provided to consumers and the medical community, the potential for Zinbryta lawsuits are also being evaluated by some product liability lawyers. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: AbbVie, Biogen, Brain Damage, Drug Recall, Encephalitis, Meningoencephalitis, Multiple Sclerosis, Zinbryta Image Credit: |More Zinbryta Lawsuit Stories Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA May 22, 2018 Zinbryta Withdrawal from U.S. Market to Be Complete April 30 March 21, 2018 Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths March 8, 2018 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: yesterday)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026) Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: 2 days ago)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026) Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 5 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths March 8, 2018
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: yesterday)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: 2 days ago)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 5 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)